Utilization and Outcomes Associated With Intravascular Ultrasound during Abdominal and Thoracic Endovascular Aortic Interventions in the United States in the Contemporary Era (2016–2023)

医学 血管内超声 危险系数 放射科 腔内修复术 腹主动脉瘤 主动脉瘤 动脉瘤 内科学 外科 心脏病学 置信区间
作者
Ramya Mosarla,Patrick Heindel,Mohamad A. Hussain,Marc L. Schermerhorn,Toshiki Kuno,Mario D’Oria,Siling Li,Eric A. Secemsky
出处
期刊:Circulation-cardiovascular Interventions [Lippincott Williams & Wilkins]
标识
DOI:10.1161/circinterventions.124.014332
摘要

BACKGROUND: Intravascular ultrasound (IVUS) use in aortic endovascular interventions, including thoracic endovascular aneurysm repair (TEVAR) and endovascular aneurysm repair (EVAR), may have similar benefits to those seen in coronary and peripheral interventions, but limited utilization and outcome data exist. METHODS: Centers for Medicare and Medicaid Services claims data were used to identify patients undergoing TEVAR and EVAR from 2016 to 2023. Utilization trends were stratified by region, urbanicity, distressed communities index, community versus academic center, Medicare versus dual enrollment status, indication, urgency, and presence of dissection with malperfusion. Inverse probability weighting was used to assess the impact of IVUS on a composite outcome of repeat aortic intervention or death. Cox regression was used to estimate weighted hazard ratios. RESULTS: A total of 136 540 patients underwent TEVAR and EVAR, of which 9.8% (13 364) used IVUS. IVUS use increased slightly from 2016 to 2023, driven more by use in TEVAR compared with EVAR, and was higher in academic settings, with Medicare and Medicaid dual enrollment, in the West, with dissections, with malperfusion and for elective procedures. IVUS was associated with a lower risk of the primary outcome at 30-days (hazard ratio, 0.80 [95% CI, 0.73–0.89]; P <0.001) and 6-months (hazard ratio, 0.93 [95% CI, 0.87–0.99]; P =0.022) for all-comers. Subgroup analysis suggested lower risks of the primary outcome with IVUS use for aneurysm driven by the abdominal segment, malperfusion, thoracoabdominal dissection with malperfusion, thoracoabdominal repair, and chronic kidney disease. CONCLUSIONS: IVUS use has increased slightly in TEVAR and EVAR with heterogeneity in use. IVUS implementation during TEVAR and EVAR was associated with improved early and mid-term outcomes, particularly in certain subsets.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
inRe完成签到,获得积分10
刚刚
xu发布了新的文献求助10
刚刚
刚刚
哇咔咔发布了新的文献求助10
刚刚
刚刚
浮华逝完成签到 ,获得积分10
刚刚
siyin发布了新的文献求助10
1秒前
坚定白风完成签到,获得积分10
1秒前
orixero的应助被姜磊宇采纳,获得10
1秒前
2秒前
粥粥发布了新的文献求助10
2秒前
尧凯发布了新的文献求助10
2秒前
星星完成签到,获得积分10
3秒前
Pxb发布了新的文献求助10
3秒前
明远发布了新的文献求助10
3秒前
吴肇泳完成签到,获得积分10
3秒前
余其钵发布了新的文献求助10
4秒前
4秒前
彭于晏的应助被wujason采纳,获得10
4秒前
4秒前
小不点完成签到,获得积分10
4秒前
超帅的薯片完成签到,获得积分10
4秒前
4秒前
4秒前
小绵羊发布了新的文献求助10
5秒前
wwwwwwtong发布了新的文献求助10
5秒前
bsdfghjnio关注了科研通微信公众号
6秒前
6秒前
6秒前
完美世界的应助被活泼的觅云采纳,获得30
6秒前
6秒前
Kelo完成签到,获得积分10
7秒前
七里香完成签到,获得积分10
7秒前
7秒前
siyin完成签到,获得积分10
8秒前
炼丹完成签到 ,获得积分10
8秒前
8秒前
笨笨人雄完成签到,获得积分10
8秒前
优秀的中心完成签到 ,获得积分10
8秒前
上官若男的应助被哇咔咔采纳,获得10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Les Mantodea De Guyane 2000
Narrative Disclosure and Earnings Performance: Evidence from R&D Disclosures 1050
内視鏡下経鼻経蝶形骨洞手術術後SIADHに対する予防的水制限の安全性と有効性の検討 1000
Positive Psychology 600
Problems and Solutions for Integer and Combinatorial Optimization: Building Skills in Discrete Optimization 600
Organizational Behavior 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8007074
求助须知:如何正确求助?哪些是违规求助? 9457537
关于积分的说明 21166818
捐赠科研通 7579561
什么是DOI,文献DOI怎么找? 3382572
关于科研通互助平台的介绍 2515138
邀请新用户注册赠送积分活动 2417407